Re: Dr. Shoemaker's Treatment Protocol

More | Report Post

On 9/21/03, ff wrote:
>
>
> johncodie:
>
> a few notes on your post:
>
> Choestyramine: if it has been recalled, I am unaware of it as it is
> still in inventory and being sold (by prescription). There are likely
> several types of recalls, and also voluntary withdrawals, which have
> nothing to do with efficacy, false claims, or reports of adverse
> effects.
>
> Ozone machines - not analogous to cholestyramine (CSM). CSM has been
> on the market for, let me guess, thirty years (as an FDA approved
> product)? I agree with you about false claims made on performance of
> a lot of products or "equipment" that continually hit the market for
> short periods of time and usually by-pass regulatory and medical
> approval.
>

Doctors increasingly recommend a low-fat diet for cholesterol control.
But instead of garlic, physicians promote prescription drugs like
cholestyramine (Questran). Cholestyramine is effective, but it costs $1
to $2 a day, requires regular professional monitoring that adds to its
cost, and may cause side effects, notably constipation, vomiting, loss of
appetite, bleeding, and vitamin deficiencies. In addition, animal
research hints that cholestyramine might accelerate tumor growth.

What we have here is a public-health no-brainer. Some people with
superelevated cholesterol levels might still need cholestyramine, but
everyone with high cholesterol should be encouraged to eat at least one
clove of garlic a day.

Unfortunately, if growers or marketers attached this information to bags
of the aromatic bulbs, the FDA could confiscate their garlic. Ditto if
they reprinted it in a pamphlet and mailed it to consumers or supermarket
produce buyers.

Why? Because under FDA regulations, using garlic to reduce cholesterol
makes the culinary herb a "drug." To the FDA, the assertion that "garlic
reduces cholesterol" constitutes a "new drug claim." The FDA has never
approved this claim, and it is a violation of FDA regulations to make
unapproved claims on drug labels or promotional materials.

SafetyAlerts
June 25, 2003
Bristol-Myers Squibb Has Recalled Cholestyramine
(SafetyAlerts) - The Food and Drug Administration (FDA) has released the
following information.

PRODUCT
Cholestyramine for Oral Suspension, USP Powder, 4 grams cholestyramine
resin, USP, per packet, 60 single dose packets, Apothecon. Recall # D-259-
3.

CODE
Lot no. 1A32512 Exp. Date 2/29/2004.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Bristol-Myers Squibb Company, New Brunswick, NJ, by
letters on April 11, 2003.
Manufacturing Firm: Bristol-Myers Squibb Company, Prinston, NJ. Firm
initiated recall is ongoing.

REASON
Superpotent (6 month stability).

VOLUME OF PRODUCT IN COMMERCE
2,011 ctns/60 packets ea.

DISTRIBUTION
Nationwide.

Your right not a total product recall. It appears the garlic growers are
looking for reasons to promote the health benefits of their product.

MCS/MCSS Chatboard

LATEST POSTS | BY TOPICS | SUBMIT A POST